Related references
Note: Only part of the references are listed.Circulating miRNAs in diabetic kidney disease: case-control study and in silico analyses
Tais S. Assmann et al.
ACTA DIABETOLOGICA (2019)
Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
Alexandra L. Matthews et al.
PLATELETS (2017)
Advanced glycation end products receptor RAGE controls myocardial dysfunction and oxidative stress in high-fat fed mice by sustaining mitochondrial dynamics and autophagy-lysosome pathway
Yichi Yu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes
Michael J. Kraakman et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
Alyssa Faria et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Human S100A7 Induces Mature Interleukin 1α Expression by RAGE-p38 MAPK-Calpain1 Pathway in Psoriasis
Hu Lei et al.
PLOS ONE (2017)
Extracellular HSP70 Activates ERK1/2, NF-κB and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells
Nauana Somensi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Activation of the receptor for advanced glycation end products and consequences on health
Marie-Paule Wautier et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
Therapeutic Interventions for Advanced Glycation-End Products and its Receptor-Mediated Cardiovascular Disease
Kailash Prasad et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway
Chen-Yuan Chiu et al.
JOURNAL OF PATHOLOGY (2016)
Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
Manasi S. Shah et al.
CIRCULATION RESEARCH (2016)
Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function
Alex Braley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Iridoid glycoside from Cornus officinalis ameliorated diabetes mellitus-induced testicular damage in male rats: Involvement of suppression of the AGEs/RAGE/p38 MAPK signaling pathway
Yuping Chen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification
Amber M. Kay et al.
JOURNAL OF DIABETES RESEARCH (2016)
Atherosclerosis and the Hypercholesterolemic AGE-RAGE Axis
Erick McNair et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2016)
ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets
Daniela Dreymueller et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
AGEs and chronic subclinical inflammation in diabetes: disorders of immune system
Hang Hu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release
So Young Eun et al.
VASCULAR PHARMACOLOGY (2015)
Oxidative stress in chronic vascular disease: From prediction to prevention
Francesca Santilli et al.
VASCULAR PHARMACOLOGY (2015)
Ratio of Serum Levels of AGEs to Soluble Form of RAGE Is a Predictor of Endothelial Function
Masato Kajikawa et al.
DIABETES CARE (2015)
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis
Christine Koulis et al.
CLINICAL SCIENCE (2014)
Role of AGEs-RAGE System in Cardiovascular Disease
Kei Fukami et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Dicarbonyl Stress and Atherosclerosis: Is It All RAGE?
Ranganath Muniyappa et al.
DIABETES (2014)
Role of advanced glycation end products in cellular signaling
Christiane Ott et al.
REDOX BIOLOGY (2014)
Cellular signalling of the receptor for advanced glycation end products (RAGE)
Jianling Xie et al.
CELLULAR SIGNALLING (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Advanced Glycation End Products and Diabetic Cardiovascular Disease
Anand Prasad et al.
CARDIOLOGY IN REVIEW (2012)
Role of advanced glycation end products in hypertension and cardiovascular risk: human studies
Marcus Baumann
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2012)
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes
Sho-ichi Yamagishi
EXPERIMENTAL GERONTOLOGY (2011)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
RAGE and soluble RAGE: Potential therapeutic targets for cardiovascular diseases
Hidenori Koyama et al.
MOLECULAR MEDICINE (2007)